Medtech Published on April 14, 2020 A team of researchers in Sherbrooke has designed a pressure ventilator that could meet the clinical needs of COVID-19. The biomedical device was developed through a competition called the “Défi respirateur code de vie”. Read more on La Tribune
Investment Published on April 9, 2020 COVID-19: The Montreal Children Hospital sets up a Paediatric Mental Health Emergency Fund to support children in times of crisis. Read more on News Wire
Medtech Published on April 9, 2020 Ten days. That’s what it took the Sherbrooke-based company IBIOM to design and manufacture a portable isolation chamber for COVID-19 patients that could have a major impact in the fight against the coronavirus. Read more on La Tribune
Medtech Published on April 8, 2020 A young Montreal-based company, Robotiques Haply, has created a low-cost, modular respirator that could help patients battling COVID-19 in remote areas. Read more on TVA News
Biotech Published on April 8, 2020 Tetra Bio-Pharma Inc, a leader in cannabinoid drug research, is joining the war effort against VIDOC-19 by mobilizing its regulatory and quality assurance teams to support Canadian companies wishing to submit their pandemic products to Health Canada. Read more on News Wire
Pharma Published on April 8, 2020 Quebec researchers are placing a lot of hope in a molecule called colchicine to reduce the serious complications caused by COVID-19. And while the first tests on patients are being conducted, Quebec-based Pharmascience is already preparing to produce large quantities. Read more on La Presse
Medtech Published on April 8, 2020 A new ventilator designed in Montreal: The Montreal-based firm CAE has completed an initial prototype ventilator, which it is working to have quickly qualified by Health Canada and put into production at its facilities. Read more on La Presse
Partnering Published on April 8, 2020 As part of the series of initiatives to find solutions to the COVID-19 pandemic, the Fonds de recherche du Québec (FRQ) are announcing the creation of the Québec COVID Network (QCN). The primary objective of the QCN is to create a space for close collaboration to coordinate research efforts, prioritize actions and accelerate discoveries and their applications for SARS-CoV-2. Read more on Québec Government
R&D Published on April 6, 2020 Researchers at the Research Institute of the McGill University Health Centre have launched a clinical trial to assess whether hydroxychloroquine (HCQ) can prevent people from contracting COVID-19 after exposure to the SARS-CoV2 virus and whether it can reduce disease-related complications and deaths. Read more on L'actualité